Zydus Lifesciences Q2 FY26 net profit rises 38%
after close1 source ↓written by the desknot a recommendation
- marking
- 38% year-on-year increase
- from operations reached
- ₹6,123.2 cr
- from the previous
- 17% growth
- company's EBITDA rose
- 38%
- ₹2,015.8 cr
Zydus Lifesciences Limited reported a net profit of ₹1,258.6 cr for Q2 FY26, marking a 38% year-on-year increase. Revenue from operations reached ₹6,123.2 cr, a 17% growth from the previous year. The company's EBITDA rose 38% to ₹2,015.8 cr, with an EBITDA margin of 32.9%. These results reflect strong business expansion and strategic investments in R&D.
Not investment advice. For informational purposes only.